An Acceptable Incidence of Infusion Site Reactions after Subcutaneous Bortezomib Administration in the Upper Arm in Japanese Patients with Multiple Myeloma

被引:1
|
作者
Ohgiya, Daisuke [1 ]
Tsuchiya, Takahide [1 ]
Suyama, Takahiro [1 ]
Watanabe, Shigeki [1 ]
Numata, Hiroki [2 ]
Tsuboi, Kosuke [2 ]
Sasao, Tamotsu [2 ]
机构
[1] Ebina Gen Hosp, Dept Hematol, Ebina, Kanagawa 2430433, Japan
[2] Ozawa Hosp, Dept Hematol, Odawara, Kanagawa, Japan
关键词
D O I
10.1159/000362587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:29 / 30
页数:2
相关论文
共 44 条
  • [41] Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients
    LeBlanc, Richard
    Ahmad, Imran
    Terra, Rafik
    Landais, Severine
    Sebag, Michael
    Lemieux-Blanchard, Emilie
    Bambace, Nadia M.
    Bernard, Lea
    Cohen, Sandra
    Delisle, Jean-Sebastien
    Kiss, Thomas
    Lachance, Silvy
    Roy, Denis-Claude
    Sauvageau, Guy
    Roy, Jean
    BLOOD, 2016, 128 (22)
  • [42] Phase II, Multicenter, Single-Arm, Open-Label Study to Evaluate the Efficacy and Safety of Panobinostat in Combination with Bortezomib and Dexamethasone in Japanese Patients with Relapsed or Relapsed-and-Refractory Multiple Myeloma
    Suzuki, Kenshi
    Sunami, Kazutaka
    Matsumoto, Morio
    Maki, Akio
    Shimada, Fumika
    Suzuki, Kazuyuki
    Shimizu, Kazuyuki
    ACTA HAEMATOLOGICA, 2021, 144 (03) : 264 - 274
  • [43] INCIDENCE OF FEBRILE EPISODES DURING STEM CELLS MOBILIZATION AFTER HIGH DOSE CYCLOPHOSPHAMIDE CHEMOTHERAPY AND G-CSF (FILGRASTIM OR LENOGRASTIM) ADMINISTRATION IN MULTIPLE MYELOMA PATIENTS: STUDY UPDATE
    Orciuolo, E.
    Buda, G.
    Marturano, E.
    Mauro, E.
    Pastore, D.
    Di Renzo, N.
    Della Cioppa, P.
    Pietrantuono, G.
    Cangialosi, C.
    Petrilli, M. P.
    Brunori, M.
    Irrera, G.
    Bartolozzi, B.
    Petrini, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 443 - 443
  • [44] Incidence of febrile episode during stem cell mobilisation after high-dose ciclophosphamide chemotherapy and G-CSF (filgrastim or lenograstim) administration in multiple myeloma patients: interim data
    Orciuolo, E.
    Buda, G.
    Battiato, K.
    Mauro, E.
    Pastore, D.
    Mazza, P.
    Pietrantuono, G.
    Di Renzo, N.
    Lombardini, L.
    Irrera, G.
    Cangialosi, C.
    Petrini, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S282 - S282